Do HEOR and HTA overlap?

Yes, HEOR (Health Economics and Outcomes Research) and HTA (Health Technology Assessment) often overlap in various areas, especially since both disciplines aim to support informed healthcare decision-making. Here’s how they intersect and complement each other:

Common Goals of HEOR and HTA

• Both HEOR and HTA aim to assess the value and impact of healthcare interventions, ensuring that they deliver benefits to patients while being economically feasible for healthcare systems.
• They support evidence-based decision-making, focusing on evaluating how effective and cost-efficient a treatment or technology is, which ultimately guides resource allocation in healthcare.

Overlapping Analytical Areas

• Cost-Effectiveness Analysis: Both HEOR and HTA use cost-effectiveness models, such as Quality-Adjusted Life Years (QALYs) or Incremental Cost-Effectiveness Ratios (ICERs), to evaluate the value of treatments. These models are critical to determining if a new therapy justifies its cost relative to its clinical benefits.
• Budget Impact Analysis: HEOR often includes budget impact studies to estimate the financial implications of adopting a new treatment, which is a key component of HTA as well.
• Patient Outcomes and Quality of Life: Both HEOR and HTA consider patient-reported outcomes and quality of life measures. HEOR collects these data to show real-world impact, while HTA includes them as part of a broader assessment on how the treatment affects patient lives.

Real-World Evidence (RWE)

• Real-World Data Collection: HEOR studies often collect real-world evidence on the effectiveness, safety, and usage patterns of treatments across diverse patient populations, outside the controlled environment of clinical trials. HTA bodies frequently incorporate this real-world evidence to understand how treatments perform in broader, less controlled settings.

Stakeholder Engagement and Data Sharing

• Both HEOR and HTA rely on collaboration with stakeholders, such as clinicians, patients, and policymakers, to ensure assessments are comprehensive and relevant to actual healthcare needs. HEOR data is often shared with HTA bodies to enhance transparency and improve decision-making accuracy.

Broader Societal Considerations

• Ethical and Societal Impact: HTA assessments often consider the ethical, social, and organizational implications of adopting new technologies, especially in public healthcare systems. While HEOR traditionally has a narrower focus on economic and clinical outcomes, it increasingly incorporates broader societal perspectives to align with HTA’s comprehensive approach.

Summary

While HEOR and HTA have unique perspectives and methodologies, they frequently overlap in their use of data and objectives. HEOR provides the economic and clinical evidence needed for HTA, while HTA places this evidence within a broader framework that considers societal and ethical factors. By working together, HEOR and HTA help to create a well-rounded view of the value of new healthcare technologies, enabling better-informed decisions in healthcare policy and practice.